GlassScriptPhysician profile
Thomas Edward Baumgarten
NPI 1962469684
$6,930.62
in general payments reported to CMS, 2019-2025
17 companies · $498 in 2025
The $498 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,143 · 2020: $105 · 2021: $198 · 2022: $1,564 · 2023: $141 · 2024: $282 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $2,159.84 | 2019-2024 | |
| Smith+Nephew, INC. | $1,613.94 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $1,207.09 | 2019-2021 | |
| Arthrex, INC. | $846.50 | 2019 | |
| Ferring Pharmaceuticals INC. | $274.14 | 2019-2025 | Euflexxa |
| Vericel Corporation | $223.82 | 2022-2025 | Maci |
| Trisalus Life Sciences, INC. | $139.77 | 2025 | Trinav Infusion System |
| Linvatec Corporation | $102.19 | 2021 | |
| Biorez, INC. | $85.93 | 2022 | |
| Abbvie INC. | $60.63 | 2021-2022 | |
| Bioventus LLC | $53.29 | 2019-2022 | |
| Pacira Therapeutics, INC. | $51.13 | 2019 | |
| Horizon Therapeutics Plc | $41.52 | 2019-2023 | Krystexxa |
| Ermi LLC | $24.42 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.59 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $16.44 | 2025 | Irrisept |
| Dynasplint Systems INC. | $13.38 | 2024 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Baumgarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.